介绍

本页面提供了有关 Joshua Lehrer-Graiwer 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Joshua Lehrer-Graiwer已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:GRPH / Graphite Bio, Inc. PRESIDENT AND CEO, Director 650,000
US:GBT / Global Blood Therapeutics Inc. Chief Medical Officer 1,875
如何解读这些图表

以下图表显示了在Joshua Lehrer-Graiwer进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

内幕交易历史

该表格显示了由 Joshua Lehrer-Graiwer 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2022-02-18 2022-02-16 4 GRPH Graphite Bio, Inc.
Stock Option (right to buy)
A - Award 650,000 650,000
2021-07-01 2021-06-29 4 GRPH Graphite Bio, Inc.
Series B Preferred Stock
C - Conversion -19,763 0 -100.00
2021-07-01 2021-06-29 4 GRPH Graphite Bio, Inc.
Common Stock
C - Conversion 8,126 1,161,670 0.70
2021-07-01 2021-03-17 4 GRPH Graphite Bio, Inc.
Stock Option (right to buy)
A - Award 340,798 340,798
2021-07-01 2021-03-17 4 GRPH Graphite Bio, Inc.
Stock Option (right to buy)
A - Award 795,196 795,196
2021-07-01 2021-03-11 4 GRPH Graphite Bio, Inc.
Series B Preferred Stock
A - Award 19,763 19,763 5.06 100,001 100,001
2021-07-01 2021-01-16 4 GRPH Graphite Bio, Inc.
Stock Option (right to buy)
M - Exercise -374,013 0 -100.00
2021-07-01 2021-01-16 4 GRPH Graphite Bio, Inc.
Common Stock
M - Exercise 374,013 1,153,544 47.98 0.30 112,204 346,063
2021-07-01 2021-01-13 4 GRPH Graphite Bio, Inc.
Stock Option (right to buy)
A - Award 374,013 374,013
2021-06-24 3 GRPH Graphite Bio, Inc.
Common Stock
1,153,544
2020-03-09 2020-03-09 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -938 1,875 -33.35
2020-03-09 2020-03-09 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -938 2,595 -26.55 59.90 -56,186 155,440
2020-03-09 2020-03-09 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 938 3,533 36.15 19.89 18,657 70,271
2020-03-09 2020-03-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,138 2,595 -30.48 65.30 -74,311 169,454
2020-03-04 2020-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -1,750 3,500 -33.33
2020-03-04 2020-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -612 3,733 -14.09 63.96 -39,144 238,763
2020-03-04 2020-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 1,750 4,345 67.44
2020-02-20 2020-02-18 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -1,313 5,250 -20.01
2020-02-20 2020-02-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,313 2,595 -33.60 69.71 -91,529 180,897
2020-02-20 2020-02-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise X 1,313 3,908 50.60 26.90 35,320 105,125
2020-02-10 2020-02-10 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -625 0 -100.00
2020-02-10 2020-02-10 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -625 2,595 -19.41 70.48 -44,050 182,896
2020-02-10 2020-02-10 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise X 625 3,220 24.08 12.95 8,094 41,699
2020-02-10 2020-02-06 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -3,937 2,595 -60.27 72.40 -285,039 187,878
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38,500 38,500
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 24,160 24,160
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -2,188 26,250 -7.69
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -1,657 13,250 -11.12
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,657 6,532 -20.23 65.00 -107,705 424,580
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise X 1,657 8,189 25.37 59.60 98,757 488,064
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -2,188 6,532 -25.09 62.81 -137,428 410,275
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise X 2,188 8,720 33.50 48.44 105,987 422,397
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,938 17,625 -14.29
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,125 8,500 -20.00
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -1,037 3,113 -24.99
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2,163 6,532 -24.88 65.26 -141,157 426,278
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6,100 8,695 235.07
2020-02-04 2020-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 579 2,595 28.72 36.68 21,238 95,185
2020-01-29 2020-01-27 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -781 4,688 -14.28
2020-01-29 2020-01-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -781 2,016 -27.92 71.15 -55,568 143,438
2020-01-29 2020-01-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 781 2,797 38.74 27.90 21,790 78,036
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,000 0 -100.00
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,984 2,016 -49.60 76.88 -152,530 154,990
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4,000 4,000
2019-12-11 2019-12-09 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -937 2,813 -24.99
2019-12-11 2019-12-09 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -937 0 -100.00 78.50 -73,554
2019-12-11 2019-12-09 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 937 937 19.89 18,637 18,637
2019-11-27 2019-11-26 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -11,593 14,907 -43.75
2019-11-27 2019-11-26 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -11,593 0 -100.00 67.19 -778,934
2019-11-27 2019-11-26 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 11,593 11,593 59.60 690,943 690,943
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -656 6,563 -9.09
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -4,594 7,219 -38.89
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -298 3,750 -7.36
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -447 0 -100.00
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -3,515 5,469 -39.13
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -1,108 4,048 -21.49
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -312 625 -33.30
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -656 0 -100.00 60.00 -39,360
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 656 656 26.90 17,646 17,646
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -4,594 0 -100.00 60.00 -275,640
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4,594 4,594 26.90 123,579 123,579
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -298 0 -100.00 60.00 -17,880
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 298 298 19.89 5,927 5,927
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -447 0 -100.00 60.00 -26,820
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 447 447 20.00 8,940 8,940
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -3,515 0 -100.00 60.00 -210,900
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 3,515 3,515 27.90 98,068 98,068
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,108 0 -100.00 60.00 -66,480
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 1,108 1,108 19.89 22,038 22,038
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -312 0 -100.00 60.00 -18,720
2019-11-27 2019-11-25 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 312 312 12.95 4,040 4,040
2019-11-20 2019-11-19 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -6,562 28,438 -18.75
2019-11-20 2019-11-19 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -6,562 0 -100.00 55.00 -360,910
2019-11-20 2019-11-19 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6,562 6,562 48.44 317,863 317,863
2019-11-20 2019-11-18 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -656 11,813 -5.26
2019-11-20 2019-11-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -656 0 -100.00 50.63 -33,213
2019-11-20 2019-11-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 656 656 26.90 17,646 17,646
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -4,594 12,469 -26.92
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -298 5,156 -5.46
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -118 447 -20.88
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -3,516 8,984 -28.13
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -1,109 5,454 -16.90
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -313 937 -25.04
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -9,948 0 -100.00 50.00 -497,447
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4,594 9,948 85.81 26.90 123,579 267,601
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 298 5,354 5.89 19.89 5,927 106,491
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 118 5,056 2.39 20.00 2,360 101,120
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 3,516 4,938 247.26 27.90 98,096 137,770
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 1,109 1,422 354.31 19.89 22,058 28,284
2019-11-18 2019-11-15 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 313 313 12.95 4,053 4,053
2019-11-18 2019-11-14 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -329 565 -36.80
2019-11-18 2019-11-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -329 0 -100.00 50.01 -16,455
2019-11-18 2019-11-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 329 329 20.00 6,580 6,580
2019-10-03 2019-10-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 1,500 1,500
2019-10-03 2019-10-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 5,000 5,000
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)